Last updated on December 2007

Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder


Brief description of study

The purpose of this study is to determine whether Duloxetine (Cymbalta®) is an effective treatment in reducing the symptoms of Posttraumatic Stress Disorder (PTSD).

Detailed Study Description

Duloxetine has established efficacy for treatment of major depression, generalized anxiety disorder and diabetic peripheral neuropathic pain. Chronic PTSD is often treated with antidepressants, in fact there are only two FDA-approved treatments for PTSD. Yet many chronic PTSD patients, especially male combat veterans, have a limited response to antidepressant treatment (Baker et al, 1995; Cañive et al, 1998; Hertzsberg et al 2000) and new pharmacotherapies should be investigated.

Clinical Study Identifier: NCT00583193

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Jose M Canive, M.D.

New Mexico VA Health Care System
Albuquerque, NM United States
  Connect »